FDA Expects Wide Range Of Peripheral Drug-Eluting Stent Applications
This article was originally published in The Gray Sheet
Executive Summary
FDA may consider granting a broad indication to leg stents based on data from the "worst" part of the leg vasculature, according to CDRH Peripheral Vascular Devices Branch Chief David Buckles, PhD
You may also be interested in...
Study Shows Promise Of Stenting Leg Arteries, But Specialist Finds Weaknesses
Nitinol stents seem to work better than angioplasty in clearing clogged leg arteries, according to a study in the May 4 New England Journal of Medicine. But a leading peripheral arterial disease physician suggests that more rigorous research is needed on the matter
Study Shows Promise Of Stenting Leg Arteries, But Specialist Finds Weaknesses
Nitinol stents seem to work better than angioplasty in clearing clogged leg arteries, according to a study in the May 4 New England Journal of Medicine. But a leading peripheral arterial disease physician suggests that more rigorous research is needed on the matter
Peripheral Vascular Devices Branch Highlights Clinical Trial Design
CDRH's Peripheral Vascular Devices Branch is considering whether companies should collect additional information during clinical trials to ensure that control and treatment groups in endograft trials are sufficiently similar